See more : Millennium Pacific Group Holdings Limited (8147.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Galaxy Biomedical Investment Co., Ltd. (000806.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Galaxy Biomedical Investment Co., Ltd., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- Trio Technology International Group Co., Ltd. (6862.TW) Income Statement Analysis – Financial Results
- Sunrise Consulting Group, Inc. (SNRS) Income Statement Analysis – Financial Results
- Novo Resources Corp. (NVO.TO) Income Statement Analysis – Financial Results
- Pretium Resources Inc. (PVG) Income Statement Analysis – Financial Results
- Nortech Systems Incorporated (NSYS) Income Statement Analysis – Financial Results
Galaxy Biomedical Investment Co., Ltd. (000806.SZ)
About Galaxy Biomedical Investment Co., Ltd.
Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China. The company produces and sells various transformer products, such as power, rectifier, and special transformers for use in metal smelting, electrochemistry, and power grid companies; and manufactures and sells electronic components, including displacement sensors, brake resistance boxes, radio frequency components, resistors, potentiometers, and others for use in aviation, aerospace, weapons, ships, AI intelligence, new energy, rail transit, communications, smart grids, instrumentation and other fields. It also offers animal products, and monoclonal antibody and targeted drugs, as well as drugs for the treatment of cancer and other diseases; laboratory equipment; and CRO, CAR-T technology and stem cell technology research and development, malignant cancer immune cell technology, and genetic testing services. The company also exports its products. The company was formerly known as Beihai Yinhe Industry Investment Co., Ltd. and changed its name to Galaxy Biomedical Investment Co., Ltd. in October 2015. Galaxy Biomedical Investment Co., Ltd. was founded in 1993 and is headquartered in Beihai, China.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.53B | 1.14B | 1.11B | 781.44M | 761.26M | 1.05B | 1.20B | 832.36M | 801.92M | 784.08M | 957.31M | 957.58M | 976.70M | 1.02B | 1.75B | 1.75B | 1.02B | 987.77M | 1.01B | 784.50M | 631.15M | 401.09M | 283.84M | 165.18M | 148.08M | 132.97M | 125.14M | 102.32M | 61.31M |
| Cost of Revenue | 985.36M | 718.31M | 720.79M | 566.84M | 603.94M | 756.18M | 889.31M | 610.68M | 587.09M | 563.49M | 736.53M | 817.92M | 740.10M | 743.46M | 1.32B | 1.31B | 815.46M | 691.89M | 748.09M | 554.85M | 448.51M | 224.18M | 141.06M | 96.90M | 95.81M | 75.34M | 77.96M | 67.37M | 39.61M |
| Gross Profit | 542.64M | 425.76M | 385.19M | 214.59M | 157.32M | 289.54M | 315.30M | 221.67M | 214.84M | 220.58M | 220.78M | 139.65M | 236.60M | 275.88M | 434.86M | 435.88M | 199.76M | 295.89M | 260.07M | 229.65M | 182.64M | 176.91M | 142.78M | 68.28M | 52.27M | 57.63M | 47.18M | 34.95M | 21.70M |
| Gross Profit Ratio | 35.51% | 37.21% | 34.83% | 27.46% | 20.67% | 27.69% | 26.17% | 26.63% | 26.79% | 28.13% | 23.06% | 14.58% | 24.22% | 27.06% | 24.78% | 24.90% | 19.68% | 29.95% | 25.80% | 29.27% | 28.94% | 44.11% | 50.30% | 41.34% | 35.30% | 43.34% | 37.70% | 34.16% | 35.40% |
| Research & Development | 69.73M | 58.97M | 34.64M | 38.23M | 100.50M | 40.38M | 38.03M | 31.73M | 10.02M | 10.63M | 10.34M | 0.00 | 10.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 37.17M | 83.25M | 37.49M | 54.95M | 63.98M | 39.36M | 44.03M | 52.35M | 34.01M | 40.64M | 41.44M | 114.21M | 21.42M | 115.00M | 142.51M | 117.89M | 132.75M | 133.46M | 119.50M | 76.15M | 55.42M | 37.24M | 31.46M | 18.60M | 16.01M | 6.13M | 5.03M | 2.69M | 2.06M |
| Selling & Marketing | 90.19M | 101.31M | 87.77M | 136.80M | 127.51M | 113.28M | 109.68M | 79.71M | 75.07M | 74.03M | 92.46M | 114.87M | 100.53M | 84.80M | 150.59M | 139.24M | 98.45M | 73.30M | 59.10M | 40.23M | 26.58M | 18.05M | 9.78M | 2.63M | 2.61M | 825.53K | 626.67K | 351.57K | 228.22K |
| SG&A | 127.35M | 184.56M | 125.26M | 191.74M | 191.49M | 152.64M | 153.71M | 132.06M | 109.07M | 114.66M | 133.90M | 229.08M | 121.95M | 199.80M | 293.09M | 257.13M | 231.20M | 206.76M | 178.59M | 116.39M | 82.01M | 55.29M | 41.24M | 21.23M | 18.62M | 6.95M | 5.65M | 3.04M | 2.29M |
| Other Expenses | 101.28M | 94.52M | 41.92M | 90.78M | -3.25M | 5.92M | 12.43M | 42.45M | -2.28M | 3.59M | 12.08M | 9.90M | 21.11M | 3.78M | 6.51M | 5.28M | -3.28M | 9.53M | -4.82M | 6.58M | 8.21M | 2.44M | 2.27M | 16.13M | 8.20M | -29.71K | 4.18M | 3.85M | 3.57M |
| Operating Expenses | 298.37M | 338.06M | 201.83M | 320.75M | 390.53M | 288.04M | 282.83M | 246.27M | 189.88M | 188.25M | 212.74M | 232.70M | 210.01M | 207.41M | 305.07M | 271.92M | 240.83M | 218.94M | 188.06M | 121.18M | 87.87M | 60.16M | 44.30M | 22.83M | 20.03M | 8.82M | 6.35M | 3.76M | 5.02M |
| Cost & Expenses | 1.28B | 1.06B | 922.61M | 887.59M | 994.47M | 1.04B | 1.17B | 856.95M | 776.97M | 751.74M | 949.27M | 1.05B | 950.11M | 950.86M | 1.63B | 1.59B | 1.06B | 910.83M | 188.06M | 676.03M | 536.38M | 284.34M | 185.35M | 119.73M | 115.84M | 84.17M | 84.31M | 71.13M | 44.62M |
| Interest Income | 198.09K | 253.96K | 184.10K | 179.70K | 331.17K | 2.10M | 4.26M | 5.69M | 931.69K | 366.36K | 1.32M | 1.51M | 1.37M | 0.00 | 631.29K | 1.40M | 6.01M | 3.94M | 18.37M | 5.37M | 9.48M | 1.32M | 2.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 18.91M | 14.54M | 20.19M | 64.22M | 64.76M | 14.90M | 9.17M | 17.64M | 57.03M | 52.15M | 73.58M | 76.20M | 91.91M | 105.00M | 138.44M | 108.83M | 89.71M | 81.33M | 53.81M | 49.48M | 32.34M | 22.36M | 10.98M | 3.57M | 3.29M | 2.72M | 1.48M | 874.23K | 800.87K |
| Depreciation & Amortization | 46.94M | 47.44M | 28.20M | -210.69M | 44.32M | 42.72M | 42.20M | 57.53M | 46.75M | 46.63M | 46.49M | 49.20M | 47.79M | 45.63M | 85.83M | 100.76M | 87.47M | 86.56M | 62.39M | 33.27M | 27.80M | 18.76M | 18.56M | 15.69M | 5.28M | 2.69M | -6.98M | -7.21M | -6.21M |
| EBITDA | 265.58M | 107.34M | 137.91M | -316.84M | -171.79M | 79.42M | 92.64M | 190.21M | 179.93M | 125.04M | 87.01M | -3.11M | 107.62M | 212.04M | 199.17M | 300.36M | 6.20M | 182.48M | 227.79M | 194.22M | 141.89M | 141.79M | 125.76M | 61.17M | 37.51M | 48.80M | 40.83M | 31.19M | 16.69M |
| EBITDA Ratio | 17.38% | 9.38% | 12.47% | -40.55% | -22.57% | 7.59% | 7.69% | 22.85% | 22.44% | 15.95% | 9.09% | -0.33% | 11.02% | 20.80% | 11.35% | 17.16% | 0.61% | 18.47% | 22.59% | 24.76% | 22.48% | 35.35% | 44.31% | 37.03% | 25.33% | 36.70% | 32.62% | 30.48% | 27.22% |
| Operating Income | 218.64M | 59.90M | 109.72M | -106.15M | -702.76M | 4.15M | 24.38M | 97.28M | 35.80M | 17.95M | 22.50M | -200.95M | -104.27M | 100.61M | -110.03M | 46.83M | -160.83M | 12.21M | 109.29M | 109.29M | 78.64M | 98.82M | 92.74M | 50.17M | 31.44M | 46.11M | 47.80M | 38.40M | 22.90M |
| Operating Income Ratio | 14.31% | 5.24% | 9.92% | -13.58% | -92.32% | 0.40% | 2.02% | 11.69% | 4.46% | 2.29% | 2.35% | -20.99% | -10.68% | 9.87% | -6.27% | 2.68% | -15.84% | 1.24% | 10.84% | 13.93% | 12.46% | 24.64% | 32.67% | 30.37% | 21.23% | 34.68% | 38.20% | 37.53% | 37.35% |
| Total Other Income/Expenses | -521.38M | -992.89M | -26.55M | -1.27B | 1.23M | 5.92M | 11.98M | 40.84M | -2.56M | 3.51M | 12.04M | 9.85M | 20.41M | -25.44M | -57.39M | -8.83M | -10.16M | 2.38M | 2.30M | 2.17M | 3.10M | 1.85M | 1.76M | 11.39M | 8.73M | -58.39K | -10.00K | -128.25K | -50.80K |
| Income Before Tax | -302.74M | -932.99M | 83.17M | -1.37B | -701.52M | 10.06M | 36.36M | 138.11M | 33.23M | 21.46M | 34.54M | -191.10M | -83.86M | 75.18M | -167.42M | 38.00M | -170.98M | 14.60M | 111.59M | 111.46M | 81.74M | 100.67M | 94.50M | 61.56M | 40.16M | 46.05M | 47.79M | 38.27M | 22.85M |
| Income Before Tax Ratio | -19.81% | -81.55% | 7.52% | -175.51% | -92.15% | 0.96% | 3.02% | 16.59% | 4.14% | 2.74% | 3.61% | -19.96% | -8.59% | 7.38% | -9.54% | 2.17% | -16.84% | 1.48% | 11.07% | 14.21% | 12.95% | 25.10% | 33.29% | 37.27% | 27.12% | 34.63% | 38.19% | 37.41% | 37.27% |
| Income Tax Expense | 33.86M | 35.48M | 21.11M | 11.27M | 39.30M | -3.88M | 19.94M | 35.53M | 10.24M | 9.09M | 8.67M | -3.55M | -12.08M | 29.93M | 18.17M | 11.82M | 9.90M | 10.45M | 9.05M | 17.26M | 12.94M | 7.27M | 5.46M | 12.35M | 9.50M | 6.91M | 7.17M | 3.00M | 2.96M |
| Net Income | -336.60M | -968.47M | 58.31M | -1.38B | -705.96M | 10.23M | 12.87M | 102.51M | 26.09M | 12.21M | 24.09M | -178.38M | -74.14M | 39.91M | -198.39M | 11.74M | -183.40M | 925.72K | 7.07M | 90.13M | 66.77M | 92.48M | 87.58M | 48.32M | 29.05M | 26.43M | 28.86M | 26.32M | 18.36M |
| Net Income Ratio | -22.03% | -84.65% | 5.27% | -176.96% | -92.74% | 0.98% | 1.07% | 12.32% | 3.25% | 1.56% | 2.52% | -18.63% | -7.59% | 3.92% | -11.30% | 0.67% | -18.06% | 0.09% | 0.70% | 11.49% | 10.58% | 23.06% | 30.86% | 29.25% | 19.62% | 19.87% | 23.06% | 25.72% | 29.95% |
| EPS | -0.31 | -0.88 | 0.05 | -1.26 | -0.64 | 0.01 | 0.01 | 0.10 | 0.04 | 0.02 | 0.03 | -0.26 | -0.11 | 0.07 | -0.30 | 0.02 | -0.27 | 0.00 | 0.12 | 0.15 | 0.09 | 0.14 | 0.13 | 0.07 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.31 | -0.88 | 0.05 | -1.26 | -0.64 | 0.01 | 0.01 | 0.10 | 0.04 | 0.02 | 0.03 | -0.26 | -0.11 | 0.07 | -0.30 | 0.02 | -0.27 | 0.00 | 0.12 | 0.15 | 0.09 | 0.14 | 0.13 | 0.07 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.00B | 699.36M | 697.87M | 698.37M | 699.24M | 699.48M | 699.39M | 667.51M | 634.48M | 667.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.00B | 699.36M | 697.87M | 698.37M | 699.24M | 699.48M | 699.39M | 667.51M | 634.48M | 667.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports